1. Mirabello, L, Troisi, RJ, Savage, SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125(1):229-234.
Google Scholar | Crossref | Medline2. Harrison, DJ, Geller, DS, Gill, JD, Lewis, VO, Gorlick, R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018;18(1):39-50.
Google Scholar | Crossref | Medline3. Joo, MW, Shin SH, Kang YK, et al. Osteosarcoma in Asian populations over the age of 40 years: a multicenter study. Ann Surg Oncol. 2015;22(11):3557-3564.
Google Scholar | Crossref | Medline4. Iwata, S, Ishii, T, Kawai, A, et al. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases. Ann Surg Oncol. 2014;21(1):263-268.
Google Scholar | Crossref | Medline5. Ozger, H, Eralp, L, Atalar, AC, et al. Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma. Acta Orthop Traumatol Turc. 2007;41(3):211-219.
Google Scholar | Medline6. Aljubran, AH, Griffin, A, Pintilie, M, Blackstein, M. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2009;20(6):1136-1141.
Google Scholar | Crossref | Medline | ISI7. Yasin, NF, Abdul Rashid, ML, Ajit Singh, V. Survival analysis of osteosarcoma patients: a 15-year experience. Journal of Orthopaedic Surgery (Hong Kong). 2020;28[1]:2309499019896662.
Google Scholar | SAGE Journals | ISI8. Savage, SA, Mirabello, L. Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma. 2011;2011:548151.
Google Scholar | Crossref | Medline9. Kumar, R, Kumar, M, Malhotra, K, Patel, S. Primary osteosarcoma in the elderly revisited: current concepts in diagnosis and treatment. Curr Oncol Rep. 2018;20(2):13.
Google Scholar | Crossref | Medline10. Longhi, A, Errani, C, Gonzales-Arabio, D, Ferrari, C, Mercuri, M. Osteosarcoma in patients older than 65 years. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2008;26(33):5368-5373.
Google Scholar | Crossref | Medline11. Tsuda, Y, Ogura, K, Shinoda, Y, Kobayashi, H, Tanaka, S, Kawai, A. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences. BMC Cancer. 2018;18(1):614.
Google Scholar | Crossref | Medline12. Nishida, Y, Isu K, Ueda T, et al. Osteosarcoma in the elderly over 60 years: a multicenter study by the Japanese musculoskeletal oncology group. J Surg Oncol. 2009;100(1):48-54.
Google Scholar | Crossref | Medline13. Grimer, RJ, Cannon SR, Taminiau AM, et al. Osteosarcoma over the age of forty. Eur J Cancer. 2003;39(2):157-163.
Google Scholar | Crossref | Medline14. Wang, Z, Wu B, Zhou Y, et al. Predictors of the survival of primary and secondary older osteosarcoma patients. J Cancer. 2019;10(19):4614-4622.
Google Scholar | Crossref | Medline15. Jeon, DG, Lee, SY, Cho, WH, Song, WS, Park, JH. Primary osteosarcoma in patients older than 40 years of age. J Korean Med Sci. 2006;21(4):715-718.
Google Scholar | Crossref | Medline16. Manoso, MW, Healey, JH, Boland, PJ, et al. De novo osteogenic sarcoma in patients older than forty: benefit of multimodality therapy. Clin Orthop Relat Res. 2005;438:110-115.
Google Scholar | Crossref | Medline17. Bacci, G, Ferrari, S, Donati, D, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity in patients in the fourth and fifth decade of life. Oncol Rep. 1998;5(5):1259-1263.
Google Scholar | Medline18. Arai, H, Ouchi, Y, Toba, K, et al. Japan as the front-runner of super-aged societies: perspectives from medicine and medical care in Japan. Geriatr Gerontol Int. 2015;15(6):673-687.
Google Scholar | Crossref | Medline19. Stark, A, Kreicbergs, A, Nilsonne, U, Silfverswärd, C. The age of osteosarcoma patients is increasing. An epidemiological study of osteosarcoma in Sweden 1971 to 1984. The Journal of Bone and Joint Surgery. British volume 1990;72(1):89-93.
Google Scholar | Crossref20. Bacci, G, Picci, P, Ferrari, S, et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer. 1993;72(11):3227-3238.
Google Scholar | Crossref | Medline | ISI21. Isakoff, MS, Bielack, SS, Meltzer, P, Gorlick, R. Osteosarcoma: current treatment and a collaborative pathway to success. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2015;33(27):3029-3035.
Google Scholar | Crossref | Medline22. Bacci, G, Ferrari, S, Mercuri, M, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41–60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999. Acta Orthop. 2007;78(3):377-384.
Google Scholar | Crossref | Medline23. Joo, MW, Shin, SH, Kang, YK, et al. Osteosarcoma in Asian populations over the age of 40 years: a multicenter study. Ann Surg Oncol. 2015;22(11):3557-3564.
Google Scholar | Crossref | Medline24. Carsi, B, Rock, MG. Primary osteosarcoma in adults older than 40 years. Clin Orthop Relat Res. 2002;397:53-61.
Google Scholar | Crossref